1. Xiao, Huiting, Wang, Kun, Li, Dan, Wang, Ke, Yu, Min. 2021. Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets. In PeerJ, 9, e10817. doi:10.7717/peerj.10817. https://pubmed.ncbi.nlm.nih.gov/33604191/
2. Zhang, Xuehong, Wang, Furong, Yan, Fanzhi, Li, Weiling, Yan, Jinsong. 2022. Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway. In Cancer cell international, 22, 40. doi:10.1186/s12935-022-02451-y. https://pubmed.ncbi.nlm.nih.gov/35081975/
3. Bi, Yanran, Zheng, Ruiling, Hu, Jiahao, Li, Xiaokun, Lin, Li. 2023. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis. In Genes & diseases, 11, 479-494. doi:10.1016/j.gendis.2023.02.035. https://pubmed.ncbi.nlm.nih.gov/37588207/
4. Waddell, Nicola, Pajic, Marina, Patch, Ann-Marie, Biankin, Andrew V, Grimmond, Sean M. . Whole genomes redefine the mutational landscape of pancreatic cancer. In Nature, 518, 495-501. doi:10.1038/nature14169. https://pubmed.ncbi.nlm.nih.gov/25719666/
5. Aleksakhina, S N, Kramchaninov, M M, Mikushina, A D, Imyanitov, E N, Iyevleva, A G. 2020. CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 23, 874-881. doi:10.1007/s12094-020-02481-w. https://pubmed.ncbi.nlm.nih.gov/32880048/
6. Flockerzi, Fidelis Andrea, Roggia, Cristiana, Langer, Frank, Holleczek, Bernd, Bohle, Rainer M. 2017. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer. In Virchows Archiv : an international journal of pathology, 472, 759-769. doi:10.1007/s00428-017-2282-0. https://pubmed.ncbi.nlm.nih.gov/29270870/
7. Jaber, Omar, Sultan, Iyad. . Adolescent presentation of FGFR1::EBF2 gene fusion mesenchymal tumor. In Genes, chromosomes & cancer, 63, e23234. doi:10.1002/gcc.23234. https://pubmed.ncbi.nlm.nih.gov/38593281/
8. Luo, Jingqin, Liu, Shuzhen, Leung, Samuel, Nielsen, Torsten O, Ellis, Matthew J. . An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors. In The Journal of molecular diagnostics : JMD, 19, 147-161. doi:10.1016/j.jmoldx.2016.09.007. https://pubmed.ncbi.nlm.nih.gov/27993329/
智鼠故事 
